2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman has been researched along with Insulin Resistance in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anandh Babu, PV; Bharath, LP; Bruno, RS; Jalili, T; Li, Y; Qian, Y; Ruan, T; Symons, JD | 1 |
1 other study(ies) available for 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and Insulin Resistance
Article | Year |
---|---|
γ-Carboxyethyl hydroxychroman, a metabolite of γ-tocopherol, preserves nitric oxide bioavailability in endothelial cells challenged with high glucose.
Topics: Biological Availability; Cells, Cultured; Chromans; Endothelium, Vascular; Glucose; Humans; Insulin Resistance; Nitric Oxide; Nitric Oxide Synthase Type III; Propionates; Reactive Oxygen Species | 2016 |